The molecular basis of cancer immunotherapy by cytotoxic T lymphocytes

被引：25

作者：

Lindauer, M ^{[1
]}

Stanislawski, T ^{[1
]}

Haussler, A ^{[1
]}

Antunes, E ^{[1
]}

Cellary, A ^{[1
]}

Huber, C ^{[1
]}

Theobald, M ^{[1
]}

机构：

[1] UNIV MAINZ,MED KLIN 3,DEPT HEMATOL,D-55101 MAINZ,GERMANY

来源：

JOURNAL OF MOLECULAR MEDICINE-JMM | 1998年 / 76卷 / 01期

关键词：

antigen presentation; cancer immunotherapy; cytotoxic T lymphocytes; T cell tolerance; tumor-associated peptide antigens;

D O I：

10.1007/s109-1998-8102-9

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

The disappointing clinical results of cancer immunotherapy of the past few decades have not diminished the optimism about the potential of the new generation of immunotherapeutic strategies towards treatment of malignant disease. Tremendous progress has been made over recent years in unveiling the molecular basis of antigen presentation and recognition by cytotoxic T lymphocytes (CTL). The molecular concepts that have emerged from these studies have led to the design of novel anticancer vaccines and CTL-based immunotherapeutics. This review is to highlight the current molecular insights of antigen presentation and CTL recognition/activation, and their impact on the rational design of therapeutic interventions that may result in protective, CTL-based antitumor immunity.

引用

页码：32 / 47

页数：16

共 191 条

[91] CD28/B7 system of T cell costimulation [J].

Lenschow, DJ ;

Walunas, TL ;

Bluestone, JA .

ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :233-258

[92] THE P53 TUMOR SUPPRESSOR GENE [J].

LEVINE, AJ ;

MOMAND, J ;

FINLAY, CA .

NATURE, 1991, 351 (6326) :453-456

[93] INHIBITION OF ANTIGEN-PROCESSING BY THE INTERNAL REPEAT REGION OF THE EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-1 [J].

LEVITSKAYA, J ;

CORAM, M ;

LEVITSKY, V ;

IMREH, S ;

STEIGERWALDMULLEN, PM ;

KLEIN, G ;

KURILLA, MG ;

MASUCCI, MG .

NATURE, 1995, 375 (6533) :685-688

[94] LOW AVIDITY RECOGNITION OF SELF-ANTIGEN BY T-CELLS PERMITS ESCAPE FROM CENTRAL TOLERANCE [J].

LIU, GY ;

FAIRCHILD, PJ ;

SMITH, RM ;

PROWLE, JR ;

KIOUSSIS, D ;

WRAITH, DC .

IMMUNITY, 1995, 3 (04) :407-415

[95] Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8 [J].

Lustgarten, J ;

Theobald, M ;

Labadie, C ;

LaFace, D ;

Peterson, P ;

Disis, ML ;

Cheever, MA ;

Sherman, LA .

HUMAN IMMUNOLOGY, 1997, 52 (02) :109-118

[96] THE 3-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROM RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC [J].

MADDEN, DR ;

GORGA, JC ;

STROMINGER, JL ;

WILEY, DC .

CELL, 1992, 70 (06) :1035-1048

[97] Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3 [J].

Marchand, M ;

Weynants, P ;

Rankin, E ;

Arienti, F ;

Belli, F ;

Parmiani, G ;

Cascinelli, N ;

Bourlond, A ;

Vanwijck, R ;

Humblet, Y ;

Canon, JL ;

Laurent, C ;

Naeyaert, JM ;

Plagne, R ;

Deraemaeker, R ;

Knuth, A ;

Jager, E ;

Brasseur, F ;

Herman, J ;

Coulie, PG ;

Boon, T .

INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (06) :883-885

[98] TOLERANCE, DANGER, AND THE EXTENDED FAMILY [J].

MATZINGER, P .

ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :991-1045

[99] DOES T-CELL TOLERANCE REQUIRE A DEDICATED ANTIGEN-PRESENTING CELL [J].

MATZINGER, P ;

GUERDER, S .

NATURE, 1989, 338 (6210) :74-76

[100] BONE-MARROW-DERIVED DENDRITIC CELLS PULSED WITH SYNTHETIC TUMOR PEPTIDES ELICIT PROTECTIVE AND THERAPEUTIC ANTITUMOR IMMUNITY [J].

MAYORDOMO, JI ;

ZORINA, T ;

STORKUS, WJ ;

ZITVOGEL, L ;

CELLUZZI, C ;

FALO, LD ;

MELIEF, CJ ;

ILDSTAD, ST ;

KAST, WM ;

DELEO, AB ;

LOTZE, MT .

NATURE MEDICINE, 1995, 1 (12) :1297-1302

← 5 6 7 8 9 10 11 12 13 14 →